Table 2.
The primary and secondary outcomes according to SHR tertiles.
| Total (n = 395) |
SHR 1st Tertile | SHR 2nd Tertile | SHR 3rd Tertile | p Value a | p Value b | |
|---|---|---|---|---|---|---|
| Admission scale c
3 4 5 |
61 (15.4) 329 (83.3) 5 (1.3) |
21 (16) 107 (81.7) 3 (2.3) |
20 (14.6) 115 (83.9) 2 (1.5) |
20 (15.7) 107 (84.3) 0 (0) |
||
| Primary outcome d | 118 (29.9) | 34 (26) | 37 (27) | 47 (37) | 0.038 | 0.054 |
| Clinical deterioration e | 104 (26.3) | 30 (22.9) | 34 (24.8) | 40 (31.5) | 0.121 | 0.227 |
| IMV | 102 (25.8) | 30 (22.9) | 32 (23.4) | 40 (31.5) | 0.121 | 0.138 |
| ICU | 118 (29.9) | 34 (26) | 37 (27) | 47 (37) | 0.038 | 0.054 |
| In-hospital mortality | 69 (17.5) | 20 (15.3) | 22 (16.1) | 27 (21.3) | 0.212 | 0.227 |
ap value when 3rd tertile was compared to 1st tertile. b p value when 3rd tertile was compared to 2nd tertile. c Grades of the ordinal scale: [3] hospitalized with no oxygen therapy; [4] hospitalized and required oxygen by mask or nasal prongs; [5] hospitalized and required high flow oxygen therapy (HFNC or NIV). d The primary outcome was a composite endpoint of ICU admission, IMV, and 28-day in-hospital mortality. e Clinical deterioration was defined as an increase in the admission ordinal scale ≥ 2 steps. Abbreviations: HFNC, high-flow nasal cannula; ICU, intensive care unit; IMV, invasive mechanical ventilation; NIV, noninvasive ventilation; SHR, stress hyperglycemia ratio. Note: All variables were expressed as frequencies and (%).